Shaping the Future of the Immunotherapeutic Development Pipeline
For the first time ever, drug developers have the option to accurately assess immunotoxicity and drug efficacy in the same study utilizing a novel humanized platform.
Learn More
For the first time ever, drug developers have the option to accurately assess immunotoxicity and drug efficacy in the same study utilizing a novel humanized platform.
Learn More
The NSG Humanized Mouse platform is an efficient way to test bispecific antibodies, including CD3 binding bispecific. This case study highlights our recent data.
Read Flipbook
The NEW cord blood CD34+ HSC humanized NSG-IL15 mouse enables efficacy research for compounds targeting human natural killer (NK) cell activity including antibody-dependent cellular cytotoxicity.
Read Flipbook
In this episode, we will be discussing what PDX models are, why they are considered more translatable, and examples of preclinical cancer studies conducted at JAX.
Watch Video
Watch Video
Read Flipbook
Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing immunodeficient mice. Learn more here: https://resources.jax.org/jax-blog/working-with-humanized-nsg-mic
Watch Video
Join Rick Huntress and Aaron Rose, Ph.D. today as they discuss the ways that JAX can support custom humanization projects, including the NBSGW or NSG-Kit (026622). Learn More at: https://www.jax.org/j
Watch Video
The term “humanized” mouse can mean many things to many people, but we’ll define it as a mouse that harbors engrafted human tissue or cells, such as immune cells. Here are some helpful tips.
Learn More
Join Drs. Kyle Draheim and Dr. Jenny Morgenweck today as they give a preview of our upcoming Immunology scientific sessions on Monday, July 20.
Watch Video
Watch this video to learn the process of generating and characterizing “humanized” NSG™ (Hu-NSG™) mice and view data demonstrating preclinical research applications of these novel mouse models.
Watch Video
Watch Video
When people think of innovation, often times they think of new products like iPhones and companies like SpaceX. But innovation spans far beyond what one may typically think of and can be applied...
Learn More
Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent mouse model. Learn more at: JAX.org/Immunodeficient-Models-YT
Watch Video
Basile Siewe, Ph.D. and Li-Chin (Lily) Yao, Ph.D., discuss cancer immunotherapies and specifically the role of NK cells in developing these therapies.
Watch Video
Searching for data JAX provides researchers free access to the Mouse Tumor Biology (MTB) database, a continuously updated repository of tumor biology data. MTB supports the use of mice as a model...
Learn More
At the end of January 2018, I attended the Hanson Wade Tumor Models Conference in San Francisco. I had the opportunity to co-present a workshop discussing The Jackson Laboratory’s Onco-Hu® Mouse...
Learn More
Developing therapies for treating cancer can sometimes feel like searching for a single needle in a profoundly heterogeneous and highly mutable haystack. Accordingly, the models and tools used to...
Learn More
The NSG™-SGM3 transgenic strain is a remarkable in vivo model generated by Dr. James Mulloy (Cincinnati Children's Hospital Medical Center). It was designed to improve the growth and engraftment...
Learn More
Chimeric Antigen Receptors: licensed to kill Cancers have cooked up ways to suppress, coerce, and evade the immune system. For instance, cancers can shut off anti-tumor T-cells, thereby...
Learn More
Loading More...